SEARCH
Merck Receives Approval of ZEPATIER™
CNW Group
2016-02-03
Views
7
Description
Share / Embed
Download This Video
Report
Merck Receives Approval of ZEPATIER™ (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review - http://dld.bz/em2kD
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x3q8ke4" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
07:08
Pfizer Covid-19 Vaccine Receives Full Approval From US FDA
00:50
Zydus Cadila’s Virafin Receives Emergency Use Approval For #COVID-19 Treatment | OTV News
01:22
LA Clippers new Inglewood arena receives final approval from City of Inglewood
04:38
ALIA Mediterranean and Middle-Eastern influences, Alaya receives stamp of approval from Dubai Ruler
00:44
'Bravo Jannik' - Sinner receives seal of approval from Italy boss Spalletti
02:26
Pres. Ferdinand R. Marcos Jr. receives high trust, approval ratings based on OCTA Research survey
01:03
Joe Jonas Receives Approval From Demi Lovato For Tell-All Interview
02:32
Karsten Energy (TSXV: KAY) receives exchange approval for its qualifying transaction tmentpitch
00:44
'Bravo Jannik' - Sinner receives seal of approval from Italy boss Spalletti
14:57
Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection
02:13
Korean biotech firm's Zika diagnostic kit receives WHO approval
01:22
LA Clippers new Inglewood arena receives final approval from City of Inglewood